Study finds annual healthcare costs per patient are significantly higher than previously described– HHT costs are higher than other ...

today announced that a study in health economics and outcomes research focused on the cost and clinical burden in people suffering with hereditary hemorrhagic telangiectasia (HHT) will be presented at ...

has designated the allosteric AKT-inhibitor VAD044 a Fast Track product for the treatment of Hereditary Hemorrhagic Telangiectasia (HHT). Fast Track is an FDA process designed to facilitate the ...

NI parents reflect on lack of services for disabled young people and call for more investment in face-to-face services to mark International Day. | UTV News ...

Politics might be a topic to avoid this Thanksgiving, but talking about family medical history could actually save you or ...

17 An individual is considered to have HHT if three of the following four diagnostic criteria are met: recurrent spontaneous epistaxis; mucocutaneous telangiectasia; visceral involvement such as ...